The novel materials intermediates industry continues to strengthen quality control, fully implementing the ISO quality management system, with products strictly benchmarked against European and American pharmacopoeia standards. Enterprises are user-need-oriented, continuously optimizing production and service systems, adhering to innovation-driven and quality-first principles, and striving to build a globally competitive brand for novel materials intermediates.